To get the reference for a specific article that have already been examined, look for it by the title. If you have forgotten the title, refer back to the estrogen homepage.
- Bartus, R.T., Dean, R.L., Beer, B., Lippa, A.S., (1982). "The cholinergic hypothesis of memory dysfunction." Science,17, 408-417.
- Barrett-Connor, E., Kritz-Silverstein, D., (1993). "Estrogen replacement therapy and cognitive function in older women. JAMA,269, 2637-2641.
- Breitner, J.C., (1991). "Clinical genetics and genetic counseling in Alzheimer's disease" Annual International Medicine, 115, 601-606.
- Birge, S.J., (1996). "Is there a role for estrogen replacement therapy in the prevention and treantment of dementia?" Journal of American Geriatric Society, 44, 860-870.
- Ganger, K.F., Vyas, S., Whitehead, M., Crook, D., Meire, H., Campbell, S. (1991). "Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause." Lancet,338, 839-842.
- Hagino, N., (1994). "Estrogen in cognetive behaviors - Clinical application of estrogen for dementia of alzheimer type." Acta Biologica Hungarica, 45, 233-247.
- Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., Hagino, N., (1994). "Evaluation of estrogen treatment in female patients with dementia of the alzheimer type." Endocrine Journal, 41, 361-371.
- Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., Hagino, N., (1995). "Long-term estrogen replacement therapy in female patients with dementia of the alzheimer type: 7 case reports." Dementia, 6, 99-107.
- Paganini-Hill, A., (1996). "Estrogen Replacement therapy in the elderly." Zentralbl Gynakol, 118, 255-261.
- Sherwin, B.B., (1996). "Hormones, moods, and cognitive Functioning in postmenopausal women." Obstetrics & Gynecology, 87 (supplement), 20s-26s.
- Stephenson, J., (1996). "More evidence links NSAID, estrogen use with reduced Alzheimer risk" [news]. JAMA, 275, 1389-1390.
- Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., Mayeux, R., (1996). "Effects of oestrogen during menapause on risk and age at onset of Alzheimer's disease." Lancet, 348, 429-432.
- Wong, M., Moss, R.L., (1992). "Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA 1 neurons." Journal of Neuroscience, 12, 3217-3225.
Other articles you might want to take a look:
Conclusion: Estradiol appeared to improve attention and orientation in three of seven postmenopausal women with Alzheimers; however, there was a loss of improvement when the estrogen was discontinued.
- Fillit, H., Weinreb, H., Cholst, I., (1986). "Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type." Psychoneuroendocrinology,11, 337-345.
Conclusion: Dementia of the Alzheimer type worsened in all four women who took estrogen for 14 days followed by an opiate antagonist.
- Weiss, B.L., (1987)."Failure of nalmefene and estrogen to improve memory in Alzheimer's disease." American Journal of Psychiatry,144, 386-387.
Conclusion: Five of seven Japanese improved scores on a dementia scale following daily treatment with estrogen.
- Honjo, H., Ogino, Y., Naitoh, K., (1989). "In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)." Journal of Steroid Biochemical Molecular Biology, 34, 511-515.